The investigators at the Harbor-UCLA Medical Center and the Miller Children's Hospital-Long Beach Memorial Medical Center propose to continue to participate as a combined unit in the scientific activities of the Children Cancer Study Group (CCSG). The applicant is a leading CCSG institution in entries onto therapeutic studies including first line, second line, and new agent studies. In addition, we are a leading institution in entries onto special studies including epidemiology studies,logy studies, and other studies either immunologic or supportive in nature. The applicant is supervising over 425 children in active follow-up. Our scientific priorities include CCSG trials of treatments, procedures, and management strategies with the objective to place eligible patients on trials of new therapeutic agents. The applicant is one of a select group of CCSG institutions approved to conduct limited institutional Phase I and Phase II studies. We have developed and are committed to continue to develop studies which will be the basis of CCSG nationwide protocols. Our research interests include special evaluations of staging, prognostic classification, epidemiology and research on the long-term effects of treatment. We are committed to continue to contribute to the following assigned CCSG activities: Wilms' Tumor Strategy Group, Pathology Committee, Supportive Care Committee, Psychology Committee, Therapeutic Committee Studies in Leukemias, Solid Tumors, and New Agents. The unit is also involved in research programs in cellular and molecular immunology which should serve as a basis for additional CCSG studies.There is a strong psychosocial program dedicated to facilitate the restoration of health and normal childhood into the community. The program is organized in a multidisciplinary manner with pediatric oncologists, surgeons, radiotherapists, pathologists, immunologists, and geneticists committed to cooperate with CCSG in the concept, design, conduct, analysis, and the reporting of clinical investigations of children with cancer. Pediatric hematologists and oncologists supervise the direct patient care and recording of data by a trained data managerial staff. Results are forwarded to the Childrens Cancer Study Group Operation's Office for compilation and statistical analysis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
2U10CA014560-16
Application #
3556264
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1976-12-01
Project End
1993-11-30
Budget Start
1988-12-15
Budget End
1989-11-30
Support Year
16
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Los Angeles County Harbor-UCLA Medical Center
Department
Type
DUNS #
City
Torrance
State
CA
Country
United States
Zip Code
90509
Seitzman, Robin L; Glover, Dorie A; Meadows, Anna T et al. (2004) Self-concept in adult survivors of childhood acute lymphoblastic leukemia: a cooperative Children's Cancer Group and National Institutes of Health study. Pediatr Blood Cancer 42:230-40
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Davies, Stella M; Bhatia, Smita; Ross, Julie A et al. (2002) Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 100:67-71
Wells, Robert J; Reid, Joel M; Ames, Matthew M et al. (2002) Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942. J Pediatr Hematol Oncol 24:89-93
Lange, Beverly J; Bostrom, Bruce C; Cherlow, Joel M et al. (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99:825-33
Ou, Shu Xiao; Han, Dehui; Severson, Richard K et al. (2002) Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 13:15-25
Cairo, M S; Krailo, M D; Morse, M et al. (2002) Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia 16:594-600
Wells, R J; Arthur, D C; Srivastava, A et al. (2002) Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia 16:601-7
Meyers, P A; Krailo, M D; Ladanyi, M et al. (2001) High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol 19:2812-20
Sposto, R; Meadows, A T; Chilcote, R R et al. (2001) Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Med Pediatr Oncol 37:432-41

Showing the most recent 10 out of 14 publications